36 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• SINTX Technologies, Inc. SINT shares increased by 34.1% to $0.88 during Wednesday's pre-market session.
• Arcturus Therapeutics, Inc. ARCT shares increased by 26.9% to $18.40. The most recent rating by Baird, on February 11, is at Outperform, with a price target of $24.00.
• Dynatronics, Inc. DYNT stock rose 20.9% to $2.14.
• Inovio Pharmaceuticals, Inc. INO stock increased by 20.8% to $9.00. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Vir Biotechnology, Inc. VIR shares increased by 14.9% to $47.06. The most recent rating by JP Morgan, on February 04, is at Neutral, with a price target of $26.00.
• UnitedHealth Group, Inc. UNH shares rose 9.5% to $286.04. The most recent rating by Deutsche Bank, on February 18, is at Hold, with a price target of $362.00.
• Anthem, Inc. ANTM stock rose 9.2% to $280.00. The most recent rating by Deutsche Bank, on February 18, is at Buy, with a price target of $362.00.
• GenMark Diagnostics, Inc. GNMK shares surged 8.5% to $4.65. The most recent rating by Needham, on March 03, is at Buy, with a price target of $11.00.
• Cigna, Inc. CI stock surged 8.4% to $205.00. The most recent rating by Piper Sandler, on February 25, is at Overweight, with a price target of $240.00.
• Zosano Pharma, Inc. ZSAN stock rose 8.4% to $0.95.
• Centene, Inc. CNC shares increased by 8.2% to $58.50. The most recent rating by Deutsche Bank, on February 18, is at Buy, with a price target of $84.00.
• Schrodinger, Inc. SDGR shares surged 5.9% to $41.85.
• NuCana, Inc. NCNA shares moved upwards by 5.7% to $8.30.
• InflaRx, Inc. IFRX shares surged 5.7% to $4.85.
• Karyopharm Therapeutics, Inc. KPTI shares moved upwards by 5.4% to $26.00. The most recent rating by Barclays, on March 04, is at Overweight, with a price target of $30.00.
• Mallinckrodt, Inc. MNK stock surged 5.1% to $3.30. The most recent rating by B of A Securities, on February 26, is at Underperform, with a price target of $3.00.
• Sorrento Therapeutics, Inc. SRNE stock rose 4.8% to $2.20.
• CVS Health, Inc. CVS shares increased by 4.8% to $65.50. The most recent rating by Deutsche Bank, on February 18, is at Buy, with a price target of $109.00.
• Rite Aid, Inc. RAD stock increased by 4.6% to $17.30.
• Cronos Group, Inc. CRON stock surged 4.5% to $5.56.
• AstraZeneca, Inc. AZN stock surged 4.3% to $47.48.
• Sanofi, Inc. SNY stock moved upwards by 3.8% to $49.53. The most recent rating by Argus Research, on February 19, is at Buy, with a price target of $56.00.
• Health Insurance, Inc. HIIQ stock increased by 3.4% to $29.04. The most recent rating by Cantor Fitzgerald, on March 04, is at Overweight, with a price target of $75.00.
• Novartis, Inc. NVS stock moved upwards by 3.4% to $86.37. According to the most recent rating by Guggenheim Securities, on February 25, the current rating is at Neutral.
• Amarin Corp, Inc. AMRN shares increased by 3.4% to $16.06. The most recent rating by Cowen & Co., on March 02, is at Outperform, with a price target of $23.00.

Losers

• Allied Healthcare Prods, Inc. AHPI stock plummeted 20.2% to $15.95 during Wednesday's pre-market session.
• Ritter Pharmaceuticals, Inc. RTTR shares decreased by 10.5% to $0.42.
• Co-Diagnostics, Inc. CODX stock fell 8.6% to $13.12. According to the most recent rating by Maxim Group, on March 03, the current rating is at Hold.
• Stealth BioTherapeutics, Inc. MITO stock fell 5.9% to $2.89. According to the most recent rating by H.C. Wainwright, on December 23, the current rating is at Neutral.
• Vaxart, Inc. VXRT stock plummeted 5.6% to $2.04.
• Novan, Inc. NOVN stock decreased by 5.4% to $0.35. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
• Guardion Health Sciences, Inc. GHSI shares plummeted 4.6% to $0.39.
• OpGen, Inc. OPGN stock decreased by 4.3% to $3.75.
• Heat Biologics, Inc. HTBX stock fell 3.9% to $0.58. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.
• Novavax, Inc. NVAX shares declined 3.7% to $10.38. The most recent rating by B. Riley FBR, on February 28, is at Buy, with a price target of $16.00.
• Altimmune, Inc. ALT shares plummeted 3.4% to $3.15.